Vector BioPharma
PrivateLast Round
Series A
Aug 10, 2022
Total Funding Raised
$30M
Company Overview
Vector BioPharma is a biotechnology company that develops a precision gene delivery platform utilizing engineered adenoviral vectors for cell- and tissue-specific delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vector BioPharma Comparables
Compare Vector BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera | 84% | |
| Nvelop Therapeutics | 83% | |
| Anjarium Biosciences | 83% |
Vector BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 10, 2022 |
Vector BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A |
Vector BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vector BioPharma's valuation, stock price, and market status.
Is Vector Biopharma a public or private company?
Vector Biopharma is a private company.
What is the current stock price of Vector Biopharma?
Vector Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Vector Biopharma worth (valuation)?
Valuation information for Vector Biopharma is not publicly available.
Can I buy Vector Biopharma stock?
Vector Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vector Biopharma's last funding round?
Vector Biopharma's most recent funding round was Series A on August 10, 2022.
Who are the main investors in Vector Biopharma?
Key investors in Vector Biopharma include Versant Ventures.
Will Vector Biopharma IPO soon?
No public IPO plans have been announced for Vector Biopharma.
How can I track Vector Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vector Biopharma's secondary market activity and sign up for updates.